Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-04-07 Sale |
2025-04-08 5:01 pm |
Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO |
3,678 | $4.5513 | $16,740 | 91,779 (Indirect Direct) |
View |
| 2025-03-13 Purchase |
2025-03-17 4:27 pm |
Phathom Pharmaceuticals Inc. | PHAT | Parikh Asit Director |
10,000 | $4.42 | $44,200 | 85,500 (Direct) |
View |
| 2025-01-21 Sale |
2025-01-23 4:24 pm |
Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO |
6,583 | $6.5883 | $43,371 | 95,457 (Indirect Direct) |
View |
| 2025-01-21 Sale |
2025-01-23 4:21 pm |
Phathom Pharmaceuticals Inc. | PHAT | Nabulsi Azmi Chief Operating Officer |
7,886 | $6.5885 | $51,957 | 1,022,669 (Indirect Direct) |
View |
| 2025-01-21 Sale |
2025-01-23 4:19 pm |
Phathom Pharmaceuticals Inc. | PHAT | Curran Terrie President and Chief Executive |
19,109 | $6.5877 | $125,884 | 364,305 (Indirect Direct) |
View |
| 2024-12-19 Sale |
2024-12-20 4:21 pm |
Phathom Pharmaceuticals Inc. | PHAT | Nabulsi Azmi Chief Operating Officer |
1,118 | $8 | $8,944 | 1,028,582 (Indirect Direct) |
View |
| 2024-12-19 Sale |
2024-12-20 4:20 pm |
Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO |
1,291 | $8 | $10,328 | 100,067 (Indirect Direct) |
View |
| 2024-12-13 Purchase |
2024-12-16 08:05 am |
Phathom Pharmaceuticals Inc. | PHAT | KARBE FRANK Director |
12,500 | $7.9267 | $99,084 | 57,000 (Direct) |
View |
| 2024-12-13 Purchase |
2024-12-16 08:05 am |
Phathom Pharmaceuticals Inc. | PHAT | Parikh Asit Director |
10,000 | $8.1248 | $81,248 | 75,500 (Direct) |
View |
| 2024-07-15 Sale |
2024-07-17 2:52 pm |
Phathom Pharmaceuticals Inc. | PHAT | Nabulsi Azmi Chief Operating Officer |
10,901 | $11.72 | $127,760 | 1,029,700 (Indirect Direct) |
View |
| 2024-07-15 Sale |
2024-07-17 2:51 pm |
Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO |
4,325 | $11.72 | $50,689 | 101,358 (Indirect Direct) |
View |
| 2024-07-15 Sale |
2024-07-17 2:50 pm |
Phathom Pharmaceuticals Inc. | PHAT | Curran Terrie President and Chief Executive |
33,848 | $11.72 | $396,699 | 381,574 (Indirect Direct) |
View |
| 2024-04-08 Sale |
2024-04-10 4:30 pm |
Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO |
3,435 | $11.1 | $38,129 | 97,174 (Indirect Direct) |
View |
| 2024-03-22 Sale |
2024-03-26 4:05 pm |
Phathom Pharmaceuticals Inc. | PHAT | Curran Terrie President and Chief Executive |
16,851 | $9.11 | $153,513 | 414,624 (Indirect Direct) |
View |
| 2024-01-24 Sale |
2024-01-25 06:13 am |
Phathom Pharmaceuticals Inc. | PHAT | TAKEDA PHARMACEUTICAL CO LTD 10% Owner |
3,703,703 | $8.1 | $29,999,994 | 3,755,583 (Direct) |
View |
| 2024-01-19 Sale |
2024-01-22 8:22 pm |
Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO |
6,307 | $7.7533 | $48,900 | 220,609 (Indirect Direct) |
View |
| 2023-11-20 Sale |
2023-11-21 4:40 pm |
Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO |
2,127 | $7.2415 | $15,403 | 104,195 (Indirect Direct) |
View |
| 2023-11-06 Purchase |
2023-11-08 7:56 pm |
Phathom Pharmaceuticals Inc. | PHAT | Parikh Asit Director |
7,500 | $7.8107 | $58,580 | 55,000 (Direct) |
View |
| 2023-11-01 Sale |
2023-11-03 4:55 pm |
Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO |
12,492 | $8.8753 | $110,871 | 106,322 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-04-16 Option Award |
2025-04-16 5:44 pm |
N/A 2035-04-15 |
Phathom Pharmaceuticals Inc. | PHAT | Schroeder Theodore R Director |
56,000 | $0 | 56,000 (Direct) |
View |
Ownership |
2025-04-16 5:37 pm |
N/A N/A |
Phathom Pharmaceuticals Inc. | PHAT | Schroeder Theodore R Director |
0 | $0 | 0 (Direct) |
View |
| 2025-04-03 Option Award |
2025-04-03 5:30 pm |
N/A N/A |
Phathom Pharmaceuticals Inc. | PHAT | Basta Steven L President and CEO |
1,445,000 | $0 | 1,445,000 (Direct) |
View |
Ownership |
2025-04-03 5:29 pm |
N/A N/A |
Phathom Pharmaceuticals Inc. | PHAT | Basta Steven L President and CEO |
0 | $0 | 0 (Direct) |
View |
| 2024-09-10 Exercise |
2025-03-21 4:46 pm |
N/A N/A |
Phathom Pharmaceuticals Inc. | PHAT | Parikh Asit Director |
7,500 | $11.72 | 100,500 (Direct) |
View |
| 2024-09-10 Exercise |
2025-03-21 4:46 pm |
2024-05-25 2033-05-24 |
Phathom Pharmaceuticals Inc. | PHAT | Parikh Asit Director |
7,500 | $0 | 100,500 (Direct) |
View |
| 2025-02-27 Option Award |
2025-03-03 5:16 pm |
N/A 2035-02-26 |
Phathom Pharmaceuticals Inc. | PHAT | Curran Terrie President and Chief Executive |
342,500 | $0 | 342,500 (Direct) |
View |
| 2025-02-27 Option Award |
2025-03-03 5:15 pm |
N/A 2035-02-26 |
Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO |
122,000 | $0 | 217,457 (Direct) |
View |
| 2025-02-27 Option Award |
2025-03-03 5:13 pm |
N/A 2035-02-26 |
Phathom Pharmaceuticals Inc. | PHAT | Nabulsi Azmi Chief Operating Officer |
134,200 | $0 | 1,156,869 (Direct) |
View |
| 2024-05-31 Option Award |
2024-05-31 6:37 pm |
N/A N/A |
Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO |
7,500 | $0 | 104,674 (Direct) |
View |
| 2024-05-31 Option Award |
2024-05-31 6:34 pm |
N/A N/A |
Phathom Pharmaceuticals Inc. | PHAT | Nabulsi Azmi Chief Operating Officer |
7,500 | $0 | 1,038,846 (Direct) |
View |
| 2024-05-29 Option Award |
2024-05-31 4:30 pm |
N/A N/A |
Phathom Pharmaceuticals Inc. | PHAT | KARBE FRANK Director |
25,000 | $10.16 | 44,500 (Direct) |
View |
| 2024-05-23 Option Award |
2024-05-24 7:47 pm |
N/A 2034-05-22 |
Phathom Pharmaceuticals Inc. | PHAT | Topper James N Director 10% Owner |
28,000 | $0 | 5,880,924 (Direct) |
View |
| 2024-05-23 Option Award |
2024-05-24 7:46 pm |
N/A 2034-05-22 |
Phathom Pharmaceuticals Inc. | PHAT | Parikh Asit Director |
28,000 | $0 | 83,000 (Direct) |
View |
| 2024-05-23 Option Award |
2024-05-24 7:44 pm |
N/A 2034-05-22 |
Phathom Pharmaceuticals Inc. | PHAT | COLA MICHAEL F Director |
28,000 | $0 | 46,798 (Direct) |
View |
| 2024-05-23 Option Award |
2024-05-24 7:43 pm |
N/A 2034-05-22 |
Phathom Pharmaceuticals Inc. | PHAT | FIELDS HEIDI Director |
28,000 | $0 | 37,000 (Direct) |
View |
| 2024-05-23 Option Award |
2024-05-24 7:33 pm |
N/A 2034-05-22 |
Phathom Pharmaceuticals Inc. | PHAT | KARBE FRANK Director |
28,000 | $0 | 37,000 (Direct) |
View |
| 2024-05-23 Option Award |
2024-05-24 7:18 pm |
N/A 2034-05-22 |
Phathom Pharmaceuticals Inc. | PHAT | Stenhouse Mark Director |
28,000 | $0 | 37,000 (Direct) |
View |
| 2024-05-23 Option Award |
2024-05-24 7:14 pm |
N/A 2034-05-22 |
Phathom Pharmaceuticals Inc. | PHAT | Socks David A Director |
28,000 | $0 | 1,248,756 (Direct) |
View |
Ownership |
2024-01-26 4:35 pm |
N/A N/A |
Phathom Pharmaceuticals Inc. | PHAT | Medicxi Ventures Management (Jersey) Ltd Medicxi Growth I GP Ltd Medicxi Growth I LP Medicxi Growth Co-Invest I LP Medicxi IV GP Ltd Medicxi IV LP Medicxi Co-Invest IV LP 10% Owner |
0 | $0 | 7,464,572 (Indirect) |
View |
| 2024-01-18 Option Award |
2024-01-22 8:22 pm |
N/A 2034-01-17 |
Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO |
120,000 | $0 | 220,609 (Direct) |
View |
| 2024-01-18 Option Award |
2024-01-22 8:21 pm |
N/A 2034-01-17 |
Phathom Pharmaceuticals Inc. | PHAT | Nabulsi Azmi Chief Operating Officer |
130,000 | $0 | 130,000 (Direct) |
View |
| 2024-01-18 Option Award |
2024-01-22 8:19 pm |
N/A 2034-01-17 |
Phathom Pharmaceuticals Inc. | PHAT | Curran Terrie President and Chief Executive |
475,000 | $0 | 475,000 (Direct) |
View |
| 2023-11-01 Option Award |
2023-11-03 4:55 pm |
N/A N/A |
Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO |
22,500 | $0 | 106,322 (Direct) |
View |